The maintenance phase is indefinite for most people
[3] Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use tirzepatide, and any symptoms such as neck mass, hoarseness, difficulty swallowing, or shortness of breath should be reported immediately
Advanced Dose 4.5 mg The highest dose tested gave the most weight loss (about 11%) over 26 weeks [1]
Texas, Georgia, New Jersey, and Ohio all sit in the riskier half of the ranking
Epithalon works by upregulating telomerase activity and thus elongating telomeres, which are sections of DNA that protect the ends of chromosomes from removal during each replication cycle on account of one strand of replication fork lagging behind the other
Karl and Spencer chat about some of the new tirzepatide studies including SURMOUNT-4 from the EASD GLP-1 Agonists and Heart Health Drs